2.1 Patients
Patients suspicious of AE were tested for autoimmune antibodies, and
patients considered as CNS demyelinating disease were tested for
demyelination antibodies. The flow diagram of inclusion criteria was
shown in Figure 1A. Exclusion criteria included: (1) follow-up month was
less than 3 months; (2) patient information was insufficient; (3)
patient was diagnosed as other antibodies positive AE or AQP4-IgG
seropositive NMOSD. After data collecting, ten patients fulfilled the
criteria and diagnosed as MOGAD overlapping with NMDAR encephalitis
between January 2018 and June 2023 at the Second Xiangya Hospital of
Central South University.